Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4566 Target Snapshot

Endothelin-1 receptor · SINGLE PROTEIN · Rattus norvegicus

1,030Compounds
84Assays
8Approved Drugs
1,044.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P26684. Use UniProt P26684 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P26684 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Endothelin-1 receptor as ChEMBL target CHEMBL4566, mapped to UniProt P26684. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Endothelin-1 receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL4566
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P26684
Endothelin-1 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Endothelin-1 receptor is the right protein anchor across sources, using UniProt P26684 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelEndothelin-1 receptor
UniProt AccessionP26684
Component TypeProtein
Sequence Length426 aa

Endothelin-1 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Endothelin-1 receptor, mapped to UniProt P26684. Sequence length is 426 aa.

Mapped IDP26684
Review nameEndothelin-1 receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

8
Approved
3
Phase III
5
Phase II
1
Phase 0.5
Assay Mix

Activity Type Distribution

IC50868.0
KI94.0
EC501.0
KD81.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL112624 10.82 IC50 0.015 Preclinical
CHEMBL4538570 10.59 IC50 0.026 Preclinical
CHEMBL298725 10.49 IC50 0.032 Preclinical
CHEMBL9194 10.47 Ki 0.034 Clinical
CHEMBL1627023 10.47 IC50 0.034 Preclinical
CHEMBL305576 10.47 Ki 0.034 Preclinical
CHEMBL437472 10.47 Ki 0.034 Clinical
CHEMBL112531 10.41 IC50 0.039 Preclinical
CHEMBL369489 10.41 IC50 0.039 Preclinical
CHEMBL323464 10.4 IC50 0.04 Preclinical
Distribution

pChEMBL Value Distribution

87
5.0
123
5.5
119
6.0
98
6.5
98
7.0
108
7.5
100
8.0
73
8.5
78
9.0
24
9.5
pChEMBL
Approved Drugs

Approved Drugs

SITAXENTAN
CHEMBL282724
Approved 2006
BOSENTAN
CHEMBL957
Approved 2001
SULFISOXAZOLE
CHEMBL453
Approved 1971
Assay Landscape

Assay Landscape

84
Total Assays
892
Tested Compounds
2
Assay Types
Binding — 60 assays, 892 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 21 487 7.1
single protein format 15 25 7.8
tissue-based format 10 251 7.2
assay format 7 77 6.7
cell membrane format 6 52 6.4
organism-based format 1 0
Functional — 24 assays, 55 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 12 49 7.2
organism-based format 5 0
cell-based format 4 4 9.2
tissue-based format 3 2 8.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine